SpyBiotech Company

SpyBiotech Operators of a biotechnology platform intended to generate next-generation vaccines.
Technology: Atrificial Vectors and Immune Cells
Industry: Atrificial Vectors and Immune Cells
Headquarters: Oxford, Oxfordshire, United Kingdom
Founded Date: 2017-01-01
Employees Number: 1-10
Funding Status: Early Stage Venture
Investors Number: 5
Total Funding: 316567683
Estimated Revenue: Less than $1M
Last Funding Date: 2021-02-10
Last Funding Type: Series A

Visit Website
Register and Claim Ownership